Table 1.
Associations of MALAT1 expression with clinical and pathological factors of breast cancer
Variables | Total No. (N=509) |
MALAT1 expression |
P value | ||
---|---|---|---|---|---|
Low No. (%) | Mid No. (%) | High No. (%) | |||
Age at Surgery (year) | |||||
≤57.80 | 253 (49.90) | 88 (34.78) | 86 (33.99) | 79 (31.23) | 0.57 |
>57.80 | 254 (50.10) | 78 (30.71) | 88 (34.65) | 88 (34.65) | |
Disease Stage | 0.30 | ||||
Stage 1 | 168 (34.93) | 49 (29.17) | 53 (31.55) | 66 (39.29) | |
Stage 2 | 241 (50.10) | 83 (34.44) | 78 (32.37) | 80 (33.20) | |
Stage 3 & 4 | 72 (14.96) | 24 (33.33) | 32 (44.44) | 16 (22.22) | |
Tumor Grade | 0.013 | ||||
Grade 1 | 60 (12.12) | 13 (21.67) | 19 (31.67) | 28 (46.67) | |
Grade 2 | 192 (38.79) | 50 (26.04) | 65 (33.85) | 77 (40.10) | |
Grade 3 | 243 (49.09) | 101 (41.56) | 83 (34.16) | 59 (24.28) | |
ER Status | 0.0002 | ||||
Positive | 349 (70.08) | 97 (27.79) | 122 (34.96) | 130 (37.25) | |
Negative | 149 (29.92) | 68 (45.64) | 48 (32.21) | 33 (22.15) | |
PR Status | <0.0001 | ||||
Positive | 295 (59.36) | 75 (25.42) | 111 (37.63) | 109 (36.95) | |
Negative | 202 (40.64) | 89 (44.06) | 59 (29.21) | 54 (26.73) |